VisMederi has expanded its testing portfolio with cutting-edge pseudo-viral platforms, which are critical tools for examining immunogenicity and developing vaccines against emerging infections.
These new technologies enable us to test immune responses in a safe and effective manner, speeding the path to innovative preventive solutions.
These are the platforms that are currently active for pseudo-viruses:
New Active Pseudo-Viral Platforms:
Seasonal Flu (Lenti)
Avian Flu (Lenti)
SARS_CoV-1(Lenti)
MERS-CoV (Lenti)
SARS-CoV-2(Lenti)
299E HCoV (Lenti)
Lassa Virus (Lenti)
Ebola Virus (Lenti-VSV)
Marburg Virus (Lenti-VSV)
Rift Valley Virus (VSV)
Rabies Virus (Lenti)
Chikungunya Virus (Lenti)
We are currently also working on pseudo-viral platforms for:
Polio Virus
HPV
This expansion enhances our ability to swiftly address the challenges of emerging diseases, supporting partners and institutions in the fight against global public health threats.
Are you interested in learning more about our platforms and collaboration opportunities? Let connect!
